The role of estrogen in adipose tissue metabolism: Insights into glucose homeostasis regulation

Endocrine Journal

Volumn 61, Issue 11, 2014, Pages 1055-1067

  Kim, Jun Ho ^a   Cho, Hyung Taek ^a   Kim, Young Jun ^a  

^a Korea University   (South Korea)

Author keywords

Adipose tissue; Estrogen; Estrogen receptors; Glucose homeostasis; Selective estrogen receptor modulators

Indexed keywords

17ALPHA ESTRADIOL; ADIPOCYTOKINE; ADIPONECTIN; BAZEDOXIFENE; BAZEDOXIFENE PLUS CONJUGATED ESTROGEN; CONJUGATED ESTROGEN; DROSPIRENONE; DYDROGESTERONE; ESTRADIOL; ESTROGEN DERIVATIVE; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; FATTY ACID; GLUCOSE; INSULIN; INTERLEUKIN 1BETA; INTERLEUKIN 6; LEVONORGESTREL; MEDROXYPROGESTERONE ACETATE; MELATONIN; NORETHISTERONE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PROGESTERONE; RALOXIFENE; SELECTIVE ESTROGEN RECEPTOR MODULATOR; TAMOXIFEN; TISSUE SELECTIVE ESTROGEN COMPLEX; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; ESTROGEN;

ADIPOCYTE; ADIPOGENESIS; ADIPOSE TISSUE CELL; ANTIDIABETIC ACTIVITY; BONE DENSITY; BREAST CANCER; CYTOKINE PRODUCTION; ER ALPHA GENE; ER BETA GENE; ESTROGEN ACTIVITY; GLUCONEOGENESIS; GLUCOSE HOMEOSTASIS; GLUCOSE METABOLISM; HORMONAL REGULATION; HOT FLUSH; HUMAN; INSULIN RELEASE; INSULIN SENSITIVITY; LIPID METABOLISM; LIPOLYSIS; MENOPAUSAL SYNDROME; METABOLIC REGULATION; METABOLIC SYNDROME X; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OBESITY; OSMOTIC PUMP; POSTMENOPAUSE; POSTMENOPAUSE OSTEOPOROSIS; PROTEIN EXPRESSION; REVIEW; RISK ASSESSMENT; SEX DIFFERENCE; SIGNAL TRANSDUCTION; TISSUE METABOLISM; TRANSDERMAL PATCH; VAGINA ATROPHY; ADIPOSE TISSUE; ANIMAL; DRUG EFFECTS; FEMALE; GROWTH, DEVELOPMENT AND AGING; HOMEOSTASIS; MALE; METABOLISM; PHYSIOLOGY;

ADIPOKINES; ADIPOSE TISSUE; ANIMALS; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; ESTROGENS; FATTY ACIDS, NONESTERIFIED; FEMALE; GLUCOSE; HOMEOSTASIS; HUMANS; MALE; POSTMENOPAUSE; SELECTIVE ESTROGEN RECEPTOR MODULATORS; SEX FACTORS; SIGNAL TRANSDUCTION;

EID: 84912135861     PISSN: 09188959     EISSN: 13484540     Source Type: Journal    
DOI: 10.1507/endocrj.EJ14-0262     Document Type: Review

References (129)

1. Kershaw EE, Flier JS (2004) Adipose tissue as an endocrine organ. J Clin Endocrinol Metab 89(6): 2548-2556.
2. Laclaustra M, Corella D, Ordovas JM (2007) Metabolic syndrome pathophysiology: the role of adipose tissue. Nutr Metab Cardiovasc Dis 17(2): 125-139.
3. Wajchenberg BL (2000) Subcutaneous and visceral adipose tissue: their relation to the metabolic syndrome. Endocr Rev 21(6): 697-738.
4. Mattsson C, Olsson T (2007) Estrogens and glucocorticoid hormones in adipose tissue metabolism. Curr Med Chem 14(27): 2918-2924.
5. Tchernof A, Calles-Escandon J, Sites CK, Poehlman ET (1998) Menopause, central body fatness, and insulin resistance: effects of hormone-replacement therapy. Coron Artery Dis 9(8): 503-511.
6. Wade GN, Gray JM, Bartness TJ (1985) Gonadal influences on adiposity. Int J Obes 9 Suppl 1: 83-92.
7. O’Sullivan AJ, Ho KK (1995) A comparison of the effects of oral and transdermal estrogen replacement on insulin sensitivity in postmenopausal women. J Clin Endocrinol Metab 80(6): 1783-1788.
8. Cooke PS, Naaz A (2004) Role of estrogens in adipocyte development and function. Exp Biol Med (Maywood) 229(11): 1127-1135.
9. Santosa S, Jensen MD (2013) Adipocyte fatty acid storage factors enhance subcutaneous fat storage in postmenopausal women. Diabetes 62(3): 775-782.
10. Chen Z, Bassford T, Green SB, Cauley JA, Jackson RD, et al. (2005) Postmenopausal hormone therapy and body composition--a substudy of the estrogen plus progestin trial of the Women’s Health Initiative. Am J Clin Nutr 82(3): 651-656.
11. Sites CK, L’Hommedieu GD, Toth MJ, Brochu M, Cooper BC, et al. (2005) The effect of hormone replacement therapy on body composition, body fat distribution, and insulin sensitivity in menopausal women: a randomized, double-blind, placebo-controlled trial. J Clin Endocrinol Metab 90(5): 2701-2707.
12. Delibasi T, Berker D, Aydin Y, Pinar T, Ozbek M (2006) Effects of combined female sex hormone replacement therapy on body fat percentage and distribution. Adv Ther 23(2): 263-273.
13. Pedersen SB, Bruun JM, Hube F, Kristensen K, Hauner H, et al. (2001) Demonstration of estrogen receptor subtypes alpha and beta in human adipose tissue: influences of adipose cell differentiation and fat depot localization. Mol Cell Endocrinol 182(1): 27-37.
14. Iverius PH, Brunzell JD (1988) Relationship between lipoprotein lipase activity and plasma sex steroid level in obese women. J Clin Invest 82(3): 1106-1112.
15. Urabe M, Yamamoto T, Kashiwagi T, Okubo T, Tsuchiya H, et al. (1996) Effect of estrogen replacement therapy on hepatic triglyceride lipase, lipoprotein lipase and lipids including apolipoprotein E in climacteric and elderly women. Endocr J 43(6): 737-742.
16. Homma H, Kurachi H, Nishio Y, Takeda T, Yamamoto T, et al. (2000) Estrogen suppresses transcription of lipoprotein lipase gene. Existence of a unique estrogen response element on the lipoprotein lipase promoter. J Biol Chem 275(15): 11404-11411.
17. Lundholm L, Zang H, Hirschberg AL, Gustafsson JA, Arner P, et al. (2008) Key lipogenic gene expression can be decreased by estrogen in human adipose tissue. Fertil Steril 90(1): 44-48.
18. Price TM, O’Brien SN, Welter BH, George R, Anandjiwala J, et al. (1998) Estrogen regulation of adipose tissue lipoprotein lipase--possible mechanism of body fat distribution. Am J Obstet Gynecol 178(1 Pt 1): 101-107.
19. Macotela Y, Boucher J, Tran TT, Kahn CR (2009) Sex and depot differences in adipocyte insulin sensitivity and glucose metabolism. Diabetes 58(4): 803-812.
20. Kuhl J, Hilding A, Ostenson CG, Grill V, Efendic S, et al. (2005) Characterisation of subjects with early abnormalities of glucose tolerance in the Stockholm Diabetes Prevention Programme: the impact of sex and type 2 diabetes heredity. Diabetologia 48(1): 35-40.
21. Louet JF, LeMay C, Mauvais-Jarvis F (2004) Antidiabetic actions of estrogen: insight from human and genetic mouse models. Curr Atheroscler Rep 6(3): 180-185.
22. Guerre-Millo M, Leturque A, Girard J, Lavau M (1985) Increased insulin sensitivity and responsiveness of glucose metabolism in adipocytes from female versus male rats. J Clin Invest 76(1): 109-116.
23. Barros RP, Gustafsson JA (2011) Estrogen receptors and the metabolic network. Cell Metab 14(3): 289-299.
24. Brown LM, Clegg DJ (2010) Central effects of estradiol in the regulation of food intake, body weight, and adiposity. J Steroid Biochem Mol Biol 122(1-3): 65-73.
25. Mauvais-Jarvis F (2011) Estrogen and androgen receptors: regulators of fuel homeostasis and emerging targets for diabetes and obesity. Trends Endocrinol Metab 22(1): 24-33.
26. Morishima A, Grumbach MM, Simpson ER, Fisher C, Qin K (1995) Aromatase deficiency in male and female siblings caused by a novel mutation and the physiological role of estrogens. J Clin Endocrinol Metab 80(12): 3689-3698.
27. Stubbins RE, Holcomb VB, Hong J, Nunez NP (2012) Estrogen modulates abdominal adiposity and protects female mice from obesity and impaired glucose tolerance. Eur J Nutr 51(7): 861-870.
28. Takeda K, Toda K, Saibara T, Nakagawa M, Saika K, et al. (2003) Progressive development of insulin resistance phenotype in male mice with complete aromatase (CYP19) deficiency. J Endocrinol 176(2): 237-246.
29. Gruber CJ, Tschugguel W, Schneeberger C, Huber JC (2002) Production and actions of estrogens. N Engl J Med 346(5): 340-352.
30. Meyer MR, Clegg DJ, Prossnitz ER, Barton M (2011) Obesity, insulin resistance and diabetes: sex differences and role of oestrogen receptors. Acta Physiol (Oxf) 203(1): 259-269.
31. Kanaya AM, Herrington D, Vittinghoff E, Lin F, Grady D, et al. (2003) Glycemic effects of postmenopausal hormone therapy: the Heart and Estrogen/progestin Replacement Study. A randomized, double-blind, placebo-controlled trial. Ann Intern Med 138(1): 1-9.
32. Knowler WC, Barrett-Connor E, Fowler SE, Hamman RF, Lachin JM, et al. (2002) Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 346(6): 393-403.
33. Bilezikian JP, Morishima A, Bell J, Grumbach MM (1998). Increased bone mass as a result of estrogen therapy in a man with aromatase deficiency. N Engl J Med 339(9): 599-603.
34. Smith EP, Boyd J, Frank GR, Takahashi H, Cohen RM, et al. (1994) Estrogen resistance caused by a mutation in the estrogen-receptor gene in a man. N Engl J Med 331(16): 1056-1061.
35. Heine PA, Taylor JA, Iwamoto GA, Lubahn DB, Cooke PS (2000) Increased adipose tissue in male and female estrogen receptor-alpha knockout mice. Proc Natl Acad Sci U S A 97(23): 12729-12734.
36. Naaz A, Zakroczymski M, Heine P, Taylor J, Saunders P, et al. (2002) Effect of ovariectomy on adipose tissue of mice in the absence of estrogen receptor alpha (ERalpha): a potential role for estrogen receptor beta (ERbeta). Horm Metab Res 34(11-12): 758-763.
37. Jones ME, Thorburn AW, Britt KL, Hewitt KN, Wreford NG, et al. (2000) Aromatase-deficient (ArKO) mice have a phenotype of increased adiposity. Proc Natl Acad Sci U S A 97(23): 12735-12740.
38. Babaei P, Mehdizadeh R, Ansar MM, Damirchi A (2010) Effects of ovariectomy and estrogen replacement therapy on visceral adipose tissue and serum adiponectin levels in rats. Menopause Int 16(3): 100-104.
39. Gambacciani M, Ciaponi M, Cappagli B, Piaggesi L, De Simone L, et al. (1997) Body weight, body fat distribution, and hormonal replacement therapy in early postmenopausal women. J Clin Endocrinol Metab 82(2): 414-417.
40. Haarbo J, Marslew U, Gotfredsen A, Christiansen C (1991) Postmenopausal hormone replacement therapy prevents central distribution of body fat after menopause. Metabolism 40(12): 1323-1326.
41. Dieudonne MN, Pecquery R, Leneveu MC, Giudicelli Y (2000) Opposite effects of androgens and estrogens on adipogenesis in rat preadipocytes: evidence for sex and site-related specificities and possible involvement of insulin-like growth factor 1 receptor and peroxisome proliferator-activated receptor gamma2. Endocrinology 141(2): 649-656.
42. Anderson LA, McTernan PG, Barnett AH, Kumar S (2001) The effects of androgens and estrogens on preadipocyte proliferation in human adipose tissue: influence of gender and site. J Clin Endocrinol Metab 86(10): 5045-5051.
43. Wada T, Ihunnah CA, Gao J, Chai X, Zeng S, et al. (2011) Estrogen sulfotransferase inhibits adipocyte differentiation. Mol Endocrinol 25(9): 1612-1623.
44. Maiorana A, Del Bianco C, Cianfarani S (2007) Adipose Tissue: A Metabolic Regulator. Potential Implications for the Metabolic Outcome of Subjects Born Small for Gestational Age (SGA). Rev Diabet Stud 4(3): 134-146.
45. Gabriely I, Ma XH, Yang XM, Atzmon G, Rajala MW, et al. (2002) Removal of visceral fat prevents insulin resistance and glucose intolerance of aging: an adipokine-mediated process? Diabetes 51(10): 2951-2958.
46. Lonnqvist F, Thorne A, Large V, Arner P (1997) Sex differences in visceral fat lipolysis and metabolic complications of obesity. Arterioscler Thromb Vasc Biol 17(7): 1472-1480.
47. Hsu IR, Kim SP, Kabir M, Bergman RN (2007) Metabolic syndrome, hyperinsulinemia, and cancer. Am J Clin Nutr 86(3): s867-871.
48. Tanaka Y, Kikuchi T, Nagasaki K, Hiura M, Ogawa Y, et al. (2005) Lower birth weight and visceral fat accumulation are related to hyperinsulinemia and insulin resistance in obese Japanese children. Hypertens Res 28(6): 529-536.
49. Kissebah AH, Alfarsi S, Adams PW, Wynn V (1976) Role of insulin resistance in adipose tissue and liver in the pathogenesis of endogenous hypertriglyceridaemia in man. Diabetologia 12(6): 563-571.
50. Cassano PA, Segal MR, Vokonas PS, Weiss ST (1990) Body fat distribution, blood pressure, and hypertension. A prospective cohort study of men in the normative aging study. Ann Epidemiol 1(1): 33-48.
51. Seidell JC, Cigolini M, Deslypere JP, Charzewska J, Ellsinger BM, et al. (1991) Body fat distribution in relation to serum lipids and blood pressure in 38-year-old European men: the European fat distribution study. Atherosclerosis 86(2-3): 251-260.
52. Bollheimer LC, Skelly RH, Chester MW, McGarry JD, Rhodes CJ (1998) Chronic exposure to free fatty acid reduces pancreatic beta cell insulin content by increasing basal insulin secretion that is not compensated for by a corresponding increase in proinsulin biosynthesis translation. J Clin Invest 101(5): 1094-1101.
53. Mason TM, Goh T, Tchipashvili V, Sandhu H, Gupta N, et al. (1999) Prolonged elevation of plasma free fatty acids desensitizes the insulin secretory response to glucose in vivo in rats. Diabetes 48(3): 524-530.
54. Shimabukuro M, Zhou YT, Levi M, Unger RH (1998) Fatty acid-induced beta cell apoptosis: a link between obesity and diabetes. Proc Natl Acad Sci U S A 95(5): 2498-2502.
55. Boden G, Chen X, Ruiz J, White JV, Rossetti L (1994) Mechanisms of fatty acid-induced inhibition of glucose uptake. J Clin Invest 93(6): 2438-2446.
56. Boden G, Chen X (1995) Effects of fat on glucose uptake and utilization in patients with non-insulin-dependent diabetes. J Clin Invest 96(3): 1261-1268.
57. Boden G, Shulman GI (2002) Free fatty acids in obesity and type 2 diabetes: defining their role in the development of insulin resistance and beta-cell dysfunction. Eur J Clin Invest 32 Suppl 3: 14-23.
58. Jensen MD, Martin ML, Cryer PE, Roust LR (1994) Effects of estrogen on free fatty acid metabolism in humans. Am J Physiol 266(6 Pt 1): E914-920.
59. Morrow PG, Marshall WP, Kim HJ, Kalkhoff RK (1981) Metabolic response to starvation. II. Effects of sex steroid administration to pre- and postmenopausal women. Metabolism 30(3): 274-278.
60. Pansini F, Bonaccorsi G, Genovesi F, Folegatti MR, Bagni B, et al. (1990) Influence of estrogens on serum free fatty acid levels in women. J Clin Endocrinol Metab 71(5): 1387-1389.
61. Pedersen SB, Kristensen K, Hermann PA, Katzenellenbogen JA, Richelsen B (2004) Estrogen controls lipolysis by up-regulating alpha2A-adrenergic receptors directly in human adipose tissue through the estrogen receptor alpha. Implications for the female fat distribution. J Clin Endocrinol Metab 89(4): 1869-1878.
62. Palin SL, McTernan PG, Anderson LA, Sturdee DW, Barnett AH (2003) 17Beta-estradiol and anti-estrogen ICI:compound 182,780 regulate expression of lipoprotein lipase and hormone-sensitive lipase in isolated subcutaneous abdominal adipocytes. Metabolism 52(4): 383-388.
63. D’Eon TM, Souza SC, Aronovitz M, Obin MS, Fried SK, et al. (2005) Estrogen regulation of adiposity and fuel partitioning. Evidence of genomic and non-genomic regulation of lipogenic and oxidative pathways. J Biol Chem 280(43): 35983-35991.
64. Bryzgalova G, Gao H, Ahren B, Zierath JR, Galuska D, et al. (2006) Evidence that oestrogen receptor-alpha plays an important role in the regulation of glucose homeostasis in mice: insulin sensitivity in the liver. Diabetologia 49(3): 588-597.
65. Gallagher CJ, Langefeld CD, Gordon CJ, Campbell JK, Mychaleckyj JC, et al. (2007) Association of the estrogen receptor-alpha gene with the metabolic syndrome and its component traits in African-American families: the Insulin Resistance Atherosclerosis Family Study. Diabetes 56(8): 2135-2141.
66. Ohlsson C, Hellberg N, Parini P, Vidal O, Bohlooly YM, et al. (2000) Obesity and disturbed lipoprotein profile in estrogen receptor-alpha-deficient male mice. Biochem Biophys Res Commun 278(3): 640-645.
67. Foryst-Ludwig A, Clemenz M, Hohmann S, Hartge M, Sprang C, et al. (2008) Metabolic actions of estrogen receptor beta (ERbeta) are mediated by a negative cross-talk with PPARgamma. PLoS Genet 4(6): e1000108.
68. Hong SC, Yoo SW, Cho GJ, Kim T, Hur JY, et al. (2007) Correlation between estrogens and serum adipocytokines in premenopausal and postmenopausal women. Menopause 14(5): 835-840.
69. Kafkas S, Dost T, Ozkayran H, Yenisey C, Tuncyurek P, et al. (2012) Effect of estrogen therapy on adipocytokines in ovariectomized-aged rats. J Obstet Gynaecol Res 38(1): 231-238.
70. Shaw KA, Hennebold JD, Edelman AB (2013) Effect of a combined estrogen and progesterone oral contraceptive on circulating adipocytokines adiponectin, resistin and DLK-1 in normal and obese female rhesus monkeys. Contraception 88(1): 177-182.
71. Ahima RS, Bjorbaek C, Osei S, Flier JS (1999) Regulation of neuronal and glial proteins by leptin: implications for brain development. Endocrinology 140(6): 2755-2762.
72. Elmquist JK, Elias CF, Saper CB (1999) From lesions to leptin: hypothalamic control of food intake and body weight. Neuron 22(2): 221-232.
73. Shimizu H, Shimomura Y, Nakanishi Y, Futawatari T, Ohtani K, et al. (1997) Estrogen increases in vivo leptin production in rats and human subjects. J Endocrinol 154(2): 285-292.
74. Machinal F, Dieudonne MN, Leneveu MC, Pecquery R, Giudicelli Y (1999) In vivo and in vitro ob gene expression and leptin secretion in rat adipocytes: evidence for a regional specific regulation by sex steroid hormones. Endocrinology 140(4): 1567-1574.
75. Ainslie DA, Morris MJ, Wittert G, Turnbull H, Proietto J, et al. (2001) Estrogen deficiency causes central leptin insensitivity and increased hypothalamic neuropeptide Y. Int J Obes Relat Metab Disord 25(11): 1680-1688.
76. Gao Q, Mezei G, Nie Y, Rao Y, Choi CS, et al. (2007) Anorectic estrogen mimics leptin’s effect on the rewiring of melanocortin cells and Stat3 signaling in obese animals. Nat Med 13(1): 89-94.
77. Arita Y, Kihara S, Ouchi N, Takahashi M, Maeda K, et al. (1999) Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. Biochem Biophys Res Commun 257(1): 79-83.
78. Lihn AS, Bruun JM, He G, Pedersen SB, Jensen PF, et al. (2004) Lower expression of adiponectin mRNA in visceral adipose tissue in lean and obese subjects. Mol Cell Endocrinol 219(1-2): 9-15.
79. Finucane FM, Luan J, Wareham NJ, Sharp SJ, O’Rahilly S, et al. (2009) Correlation of the leptin:adiponectin ratio with measures of insulin resistance in non-diabetic individuals. Diabetologia 52(11): 2345-2349.
80. Zhuo Q, Wang Z, Fu P, Piao J, Tian Y, et al. (2009) Comparison of adiponectin, leptin and leptin to adiponectin ratio as diagnostic marker for metabolic syndrome in older adults of Chinese major cities. Diabetes Res Clin Pract 84(1): 27-33.
81. Kim JH, Meyers MS, Khuder SS, Abdallah SL, Muturi HT, et al. (2014) Tissue-selective estrogen complexes with bazedoxifene prevent metabolic dysfunction in female mice. Mol Metab 3(2): 177-190.
82. Combs TP, Berg AH, Rajala MW, Klebanov S, Iyengar P, et al. (2003) Sexual differentiation, pregnancy, calorie restriction, and aging affect the adipocyte-specific secretory protein adiponectin. Diabetes 52(2): 268-276.
83. Miyatani Y, Yasui T, Uemura H, Yamada M, Matsuzaki T, et al. (2008) Associations of circulating adiponectin with estradiol and monocyte chemotactic protein-1 in postmenopausal women. Menopause 15(3): 536-541.
84. Sartipy P, Loskutoff DJ (2003) Monocyte chemoattractant protein 1 in obesity and insulin resistance. Proc Natl Acad Sci U S A 100(12): 7265-7270.
85. Cantatore FP, Loverro G, Ingrosso AM, Lacanna R, Sassanelli E, et al. (1995) Effect of oestrogen replacement on bone metabolism and cytokines in surgical menopause. Clin Rheumatol 14(2): 157-160.
86. Deswal A, Petersen NJ, Feldman AM, Young JB, White BG, et al. (2001) Cytokines and cytokine receptors in advanced heart failure: an analysis of the cytokine database from the Vesnarinone trial (VEST). Circulation 103(16): 2055-2059.
87. Van Bezooijen RL, Farih-Sips HC, Papapoulos SE, Lowik CW (1998) IL-1alpha, IL-1beta, IL-6, and TNF-alpha steady-state mRNA levels analyzed by reverse transcription-competitive PCR in bone marrow of gonadectomized mice. J Bone Miner Res 13(2): 185-194.
88. Bernard-Poenaru O, Roux C, Blanque R, Gardner C, de Vemejoul MC, et al. (2001) Bone-resorbing cytokines from peripheral blood mononuclear cells after hormone replacement therapy: a longitudinal study. Osteoporos Int 12(9): 769-776.
89. Zuckerman SH, Bryan-Poole N, Evans GF, Short L, Glasebrook AL (1995) In vivo modulation of murine serum tumour necrosis factor and interleukin-6 levels during endotoxemia by oestrogen agonists and antagonists. Immunology 86(1): 18-24.
90. Rogers A, Eastell R (2001) The effect of 17beta-estradiol on production of cytokines in cultures of peripheral blood. Bone 29(1): 30-34.
91. Scheidt-Nave C, Bismar H, Leidig-Bruckner G, Woitge H, Seibel MJ, et al. (2001) Serum interleukin 6 is a major predictor of bone loss in women specific to the first decade past menopause. J Clin Endocrinol Metab 86(5): 2032-2042.
92. Straub RH, Hense HW, Andus T, Scholmerich J, Riegger GA, et al. (2000) Hormone replacement therapy and interrelation between serum interleukin-6 and body mass index in postmenopausal women: a population-based study. J Clin Endocrinol Metab 85(3): 1340-1344.
93. Gregory MS, Duffner LA, Faunce DE, Kovacs EJ (2000) Estrogen mediates the sex difference in post-burn immunosuppression. J Endocrinol 164(2): 129-138.
94. Ahima RS, Flier JS (2000) Adipose tissue as an endocrine organ. Trends Endocrinol Metab 11(8): 327-332.
95. Stubbins RE, Najjar K, Holcomb VB, Hong J, Nunez NP (2012) Oestrogen alters adipocyte biology and protects female mice from adipocyte inflammation and insulin resistance. Diabetes Obes Metab 14(1): 58-66.
96. Yang Q, Graham TE, Mody N, Preitner F, Peroni OD, et al. (2005) Serum retinol binding protein 4 contributes to insulin resistance in obesity and type 2 diabetes. Nature 436(7049): 356-362.
97. Tan BK, Chen J, Lehnert H, Kennedy R, Randeva HS (2007) Raised serum, adipocyte, and adipose tissue retinol-binding protein 4 in overweight women with polycystic ovary syndrome: effects of gonadal and adrenal steroids. J Clin Endocrinol Metab 92(7): 2764-2772.
98. Fried SK, Greenberg AS (2012) Lipocalin 2: a “sexy” adipokine that regulates 17beta-estradiol and obesity. Endocrinology 153(4): 1582-1584.
99. Guo H, Zhang Y, Brockman DA, Hahn W, Bernlohr DA, et al. (2012) Lipocalin 2 deficiency alters estradiol production and estrogen receptor signaling in female mice. Endocrinology 153(3): 1183-1193.
100. Mauvais-Jarvis F, Clegg DJ, Hevener AL (2013) The role of estrogens in control of energy balance and glucose homeostasis. Endocr Rev 34(3): 309-338.
101. Le May C, Chu K, Hu M, Ortega CS, Simpson ER, et al. (2006) Estrogens protect pancreatic beta-cells from apoptosis and prevent insulin-deficient diabetes mellitus in mice. Proc Natl Acad Sci U S A 103(24): 9232-9237.
102. Lipscombe LL, Fischer HD, Yun L, Gruneir A, Austin P, et al. (2012) Association between tamoxifen treatment and diabetes: a population-based study. Cancer 118(10): 2615-2622.
103. Ettinger B, Black DM, Mitlak BH, Knickerbocker RK, Nickelsen T, et al. (1999) Reduction of vertebral fracture risk in postmenopausal women with osteoporosis treated with raloxifene: results from a 3-year randomized clinical trial. Multiple Outcomes of Raloxifene Evaluation (MORE) Investigators. JAMA 282(7): 637-645.
104. Meli R, Pacilio M, Raso GM, Esposito E, Coppola A, et al. (2004) Estrogen and raloxifene modulate leptin and its receptor in hypothalamus and adipose tissue from ovariectomized rats. Endocrinology 145(7): 3115-3121.
105. Tiano J, Mauvais-Jarvis F (2012) Selective estrogen receptor modulation in pancreatic beta-cells and the prevention of type 2 diabetes. Islets 4(2): 173-176.
106. Andersson B, Johannsson G, Holm G, Bengtsson BA, Sashegyi A, et al. (2002) Raloxifene does not affect insulin sensitivity or glycemic control in postmenopausal women with type 2 diabetes mellitus: a randomized clinical trial. J Clin Endocrinol Metab 87(1): 122-128.
107. Nagamani M, Szymajda A, Sepilian V, Urban RJ, Gilkison C (2008) Effects of raloxifene on insulin sensitivity, beta-cell function, and hepatic insulin extraction in normal postmenopausal women. Fertil Steril 89(3): 614-619.
108. Lee CC, Kasa-Vubu JZ, Supiano MA (2003) Differential effects of raloxifene and estrogen on insulin sensitivity in postmenopausal women. J Am Geriatr Soc 51(5): 683-688.
109. Lasco A, Gaudio A, Morabito N, Previti M, Mileto A, et al. (2004) Effects of a long-term treatment with raloxifene on insulin sensitivity in postmenopausal women. Diabetologia 47(3): 571-574.
110. Biskobing DM (2007) Update on bazedoxifene: a novel selective estrogen receptor modulator. Clin Interv Aging 2(3): 299-303.
111. Komm BS, Vlasseros F, Samadfam R, Chouinard L, Smith SY (2011) Skeletal effects of bazedoxifene paired with conjugated estrogens in ovariectomized rats. Bone 49(3): 376-386.
112. Lindsay R, Gallagher JC, Kagan R, Pickar JH, Constantine G (2009) Efficacy of tissue-selective estrogen complex of bazedoxifene/conjugated estrogens for osteoporosis prevention in at-risk postmenopausal women. Fertil Steril 92(3): 1045-1052.
113. Gruber C, Gruber D (2004) Bazedoxifene (Wyeth). Curr Opin Investig Drugs 5(10): 1086-1093.
114. Lobo RA, Pinkerton JV, Gass ML, Dorin MH, Ronkin S, et al. (2009) Evaluation of bazedoxifene/conjugated estrogens for the treatment of menopausal symptoms and effects on metabolic parameters and overall safety profile. Fertil Steril 92(3): 1025-1038.
115. Clarkson TB, Ethun KF, Chen H, Golden D, Floyd E, et al. (2013) Effects of bazedoxifene alone and with conjugated equine estrogens on coronary and peripheral artery atherosclerosis in postmenopausal monkeys. Menopause 20(3): 274-281.
116. Karakus M, Gelisgen R, Topcuoglu A, Guralp O, Topcuoglu D, et al. (2012) The effects of 17β-estradiol plus drospirenone on anthropometric and biochemical measures of adiposity in menopausal women. Arch Gynecol Obstet 286: 1233-1239.
117. Tanko LB, Christiansen C (2005) Effects of 17β-oestradiol plus different doses of drospirenone on adipose tissue, adiponectin and atherogenic metabolites in postmenopausal women. J Intern Med 258: 544-553.
118. Castelo-Branco C, Palacios S, Vázquez F, Villero J, Ferrer J, et al. (2007) Effects on serum lipid and leptin levels of three different doses of norethisterone continuously combined with a fixed dose of 17β-estradiol for nasal administration in postmenopausal women: a controlled, double-blind study. Fertil Steril 88: 383-389.
119. Cooper BC, Burger NZ, Toth MJ, Cushman M, Sites CK (2007) Insulin resistance with hormone replacement therapy: associations with markers of inflammation and adiposity. Am J Obstet Gynecol 196: 123.e1-7.
120. Im JA, Lee JW, Lee HR, Lee DC (2006) Plasma adiponectin levels in postmenopausal women with or without long-term hormone therapy. Maturitas 54: 65-71.
121. Gower BA, Nagy TR, Goran MI, Smith A, Kent E (2000) Leptin in postmenopausal women: influence of hormone therapy, insulin, and fat distribution. J Clin Endocrinol Metab 85: 1770-1775.
122. Bednarek-Tupikowska G, Filus A, Kuliczkowska-Plaksej J, Tupikowski K, Bohdanowicz-Pawlak A, et al. (2006) Serum leptin concentrations in pre-and postmenopausal women on sex hormone therapy. Gynecol Endocrinol 22: 207-212.
123. Rizzo MR, Leo S, De Franciscis P, Colacurci N, Paolisso G (2014) Short-term effects of low-dose estrogen/drospirenone vs low-dose estrogen/dydrogesterone on glycemic fluctuations in postmenopausal women with metabolic syndrome. Age 36: 265-274.
124. Salbach B, Nawroth PP, Kübler W, Von Holst TH, Salbach PB (2000) Serum leptin levels and body weight in postmenopausal women under transdermal hormone replacement therapy. Eur J Med Res 5: 63-66.
125. Elbers JM, De Roo GW, Popp-Snijders C, Nicolaas-Merkus A, Westerveen E, et al. (1999). Effects of administration of 17β-oestradiol on serum leptin levels in healthy postmenopausal women. Clin Endocrinol (Oxf) 51: 449-454.
126. Xu J, Xiang Q, Lin G, Fu X, Zhou K, et al. (2012) Estrogen improved metabolic syndrome through down-regulation of VEGF and HIF-1α to inhibit hypoxia of periaortic and intra-abdominal fat in ovariectomized female rats. Mol Biol Rep 39: 8177-8185.
127. Rachon D, Vortherms T, Seidlovä-Wuttke D, Wuttke W (2007) Effects of dietary equol on body weight gain, intra-abdominal fat accumulation, plasma lipids, and glucose tolerance in ovariectomized Sprague-Dawley rats. Menopause 14: 925-932.
128. Sanchez-Mateos S, Alonso-Gonzalez C, Gonzalez A, Martinez-Campa CM, Mediavilla MD, et al. (2007) Melatonin and estradiol effects on food intake, body weight, and leptin in ovariectomized rats. Maturitas 58: 91-101.
129. Zoth N, Weigt C, Laudenbach-Leschowski U, Diel P (2010) Physical activity and estrogen treatment reduce visceral body fat and serum levels of leptin in an additive manner in a diet induced animal model of obesity. J Steroid Biochem Mol Biol 122: 100-105.